The promising effect of NADH on athletic performance

Four studies - Birkmayer and Vank, Misner et al., Grathwohl et al. and Mero et al. - investigated the influence of NADH on athletic performance . Overall, the results showed that NADH can improve muscular energy provision and lead to increased performance during physical exertion.

The study by Birkmayer and Vank investigated whether NADH supplementation can improve psychomotor and physical performance in athletes. The results showed that NADH improved athletes' performance and led to faster recovery after exercise.

The study by Misner et al. examined the influence of NADH on muscle energy provision during short- and long-term exercise with the result that NADH contributed to improved energy provision and enabled faster recovery after exercise.

The study by Grathwohl et al. investigated whether NADH supplementation can improve muscular energy provision during exercise. The results showed that NADH improved maximal muscle performance and anaerobic energy provision.

The study by Mero et al. investigated the influence of NADH on the physical and mental performance of athletes and showed that NADH improved physical performance during intense exercise and also contributed to faster recovery after exercise. In addition, the study also showed that NADH improved mental performance, especially attention and reaction time.

In summary, these results suggest that NADH may be a promising supplement for athletes to improve their physical and mental performance and shorten their recovery time after exercise. However, it remains to be noted that more research is needed to determine the optimal dosages and intake times of NADH and to investigate the long-term effects on performance.

Source: Georg D. Birkmayer, M.D., Ph.D., Pavel Vank, M.D., Birkmayer Institute for Parkinson Therapy, Research Division, Vienna, Austria: Reduced Conenzyme 1 (NADH) improves psychomotor and physical performance in athletes; International Journal of Sports Medicine April, 1996.

Source: Bill Misner, Ph.D.(Washington, USA), George D. Birkmayer(Vienna, Austria), H. Schlachter (Munich, Germany), and A. Berg (Freiburg, Germany): The coenzyme Nicotinamide Adenine Dinucleotide(NADH) as a biological ergogenic factor in short-term and prolonged exercise.

Source: Grathwohl D, Klann M, Müller HM, Schlachter H, Berg A.: Einfluss einer NADH Supplementation auf die muskuläre Energiebereitstellung bei Menschen (Influence of NADH supplementation for the muscular energy supply in humans) Deutsche Zeitschrift für Sportmedizin, 11/2000.

Source: Antti A. Mero, Riikka T. Raitanen, George D. Birkmayer and Paavo V. Komi: Effects of Nicotinamide Adenine Dinucleotide Hydride on physical and mental performance; Manuscript / Journal of Sports Sciences 19.9. 2006


Leave a comment

Please note that comments must be approved before publication

This website is protected by hCaptcha and the terms and conditions and privacy policy of hCaptcha apply.


FAQs

The term “weight-loss injection” refers to various
prescription medications that are used under certain
medical conditions to treat overweight and obesity
. Well-known active ingredients include semaglutide and tirzepatide.
Among other things, they influence hunger and feelings of fullness and can thereby
reduce energy intake.

GLP-1 stands for glucagon-like peptide-1 and is a naturally occurring hormone in the body
. Among other things, it plays a role in regulating
appetite, satiety, and glucose metabolism. GLP-1-based medications mimic
the effects of this hormone and specifically activate the GLP-1 receptor.

The term “GLP-1 dietary supplement” is not medically defined at
. It generally refers to products marketed as “GLP-1 Support”
or “GLP-1 Booster,” which may contain, for example, dietary fiber,
protein, prebiotics, or plant compounds such as berberine.

What matters most here is the specific ingredient and its scientifically studied effects (
)—not just the name of the product (
).

Dietary supplements and GLP-1 medications
have different mechanisms of action. Medications such as semaglutide or tirzepatide
specifically target certain hormonal signaling pathways. Certain nutrients
and plant compounds, on the other hand, can support other physiological processes,
such as satiety, digestion, or metabolism.

They should therefore not be equated with the pharmacological effects
of GLP-1 medications
.

Of particular interest are ingredients associated with satiety,
digestion, or the gut microbiota. These include , for example ,
soluble and fermentable dietary fibers, prebiotics, and
certain plant compounds
.

Among other things, dietary fiber can influence digestion
and, through fermentation in the gut, contribute to the formation of short-chain
fatty acids. These, in turn, can influence signaling pathways associated with
the release of gut hormones such as GLP-1.

However, the effect depends heavily on the specific ingredient,
the dosage, and the individual's situation.

Dietary fiber can contribute to a balanced diet
and, among other things, promote satiety and aid digestion.
Soluble and fermentable dietary fibers are particularly noteworthy in this context
.

Good natural sources include vegetables,
legumes, whole grains, fruits, nuts, and seeds. Certain
dietary fibers, such as psyllium or inulin, are also used as dietary supplements.

Protein provides important amino acids for the maintenance and
growth of muscle tissue. An adequate protein intake is therefore particularly important
during significant weight loss.

When combined with regular strength training,
a high-protein diet can help preserve lean body mass as much as possible during
weight loss.

In general, there is no comprehensive list of
foods that are strictly prohibited during GLP-1 therapy.
However, appetite, feelings of fullness, and, in some cases,
tolerance to certain foods may change.

When people eat less overall, the nutritional quality of their diet
becomes more important. Protein-rich foods, vegetables, fruits,
whole grains, legumes, and other nutrient-dense foods can
serve as an important foundation.

Studies show that weight regain can occur after discontinuing GLP-1-based
medications. In the extension
of the STEP-1 study, participants regained, on average, a significant portion of the weight they had previously
lost within one year of
discontinuing semaglutide.

This underscores the importance of long-term, sustainable
dietary and physical activity habits, even during medication-based
therapy.

GLP-1 therapy does not require a specific diet
. However, since feelings of hunger and fullness change and
people sometimes eat less, it may be helpful to focus
particularly on nutrient density, protein, fiber, and a
varied selection of foods
.

Regular exercise, especially strength training, can also be a useful addition to
.

No. GLP-1 dietary supplements and
GLP-1 medications must always be distinguished from one another.

Drugs such as semaglutide and tirzepatide were specifically developed
to activate certain hormonal signaling pathways and have been studied as medications in
clinical trials. Dietary supplements
, on the other hand, contain nutrients or other bioactive substances that can support natural
physiological processes.

The term “GLP-1” on a dietary supplement
therefore does not mean that the product has the same effect as a GLP-1 medication
.